nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—Vitamin A—ALDH1A1—kidney cancer	0.00572	0.256	CrCbGaD
Isotretinoin—Tretinoin—ALDH1A1—kidney cancer	0.00553	0.247	CrCbGaD
Isotretinoin—Alitretinoin—CRABP1—kidney cancer	0.00544	0.243	CrCbGaD
Isotretinoin—Tretinoin—CRABP1—kidney cancer	0.00383	0.172	CrCbGaD
Isotretinoin—Vitamin A—CYP1A1—kidney cancer	0.000674	0.0302	CrCbGaD
Isotretinoin—Tretinoin—CYP1A1—kidney cancer	0.000651	0.0292	CrCbGaD
Isotretinoin—RXRB—Gene Expression—EIF5B—kidney cancer	0.000518	0.00213	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—EIF5B—kidney cancer	0.000518	0.00213	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—MAPK3—kidney cancer	0.000502	0.00207	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—kidney cancer	0.000499	0.00205	CbGpPWpGaD
Isotretinoin—Alitretinoin—ABCB1—kidney cancer	0.000491	0.022	CrCbGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000491	0.00202	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000486	0.002	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000482	0.00198	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—MAPK1—kidney cancer	0.000478	0.00197	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTT1—kidney cancer	0.000464	0.00191	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC5A5—kidney cancer	0.000456	0.00187	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC2A1—kidney cancer	0.00044	0.00181	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—PTGS1—kidney cancer	0.000435	0.00179	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—L1CAM—kidney cancer	0.00043	0.00177	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SPTBN4—kidney cancer	0.00043	0.00177	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000427	0.00176	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—EGR1—kidney cancer	0.000409	0.00168	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000404	0.00166	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—CYP1A1—kidney cancer	0.000401	0.00165	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000394	0.00162	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000392	0.00161	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—kidney cancer	0.000392	0.00161	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—JUNB—kidney cancer	0.000391	0.00161	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—EEF2—kidney cancer	0.000388	0.0016	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000388	0.00159	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000386	0.00159	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000384	0.00158	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—CTNNB1—kidney cancer	0.000381	0.00157	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CER1—kidney cancer	0.000376	0.00155	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—TET2—kidney cancer	0.000372	0.00153	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSTP1—kidney cancer	0.000367	0.00151	CbGpPWpGaD
Isotretinoin—RXRA—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.000358	0.00147	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—CTNNB1—kidney cancer	0.000358	0.00147	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—JUNB—kidney cancer	0.000357	0.00147	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—EEF2—kidney cancer	0.000355	0.00146	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000352	0.00145	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000352	0.00145	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—JUNB—kidney cancer	0.00035	0.00144	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—EEF2—kidney cancer	0.000348	0.00143	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—TCEB2—kidney cancer	0.00034	0.0014	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—TCEB1—kidney cancer	0.00034	0.0014	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—TET2—kidney cancer	0.00034	0.0014	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HNF1A—kidney cancer	0.00034	0.0014	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EPAS1—kidney cancer	0.00034	0.0014	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSTM1—kidney cancer	0.000337	0.00139	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—JUNB—kidney cancer	0.000336	0.00138	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—JUNB—kidney cancer	0.000336	0.00138	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—EEF2—kidney cancer	0.000334	0.00137	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—EEF2—kidney cancer	0.000334	0.00137	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—TET2—kidney cancer	0.000334	0.00137	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.00033	0.00136	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—kidney cancer	0.000326	0.00134	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTP1—kidney cancer	0.000322	0.00132	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—TET2—kidney cancer	0.00032	0.00132	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—TET2—kidney cancer	0.00032	0.00132	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000318	0.00131	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000317	0.00131	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HARS—kidney cancer	0.000317	0.0013	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000314	0.00129	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—HIF1A—kidney cancer	0.000312	0.00128	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—TCEB2—kidney cancer	0.000311	0.00128	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—TCEB1—kidney cancer	0.000311	0.00128	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000307	0.00126	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—TCEB2—kidney cancer	0.000305	0.00125	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—TCEB1—kidney cancer	0.000305	0.00125	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000304	0.00125	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000301	0.00124	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—kidney cancer	0.0003	0.00123	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTM1—kidney cancer	0.000296	0.00122	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000294	0.00121	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—TCEB2—kidney cancer	0.000292	0.0012	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—TCEB1—kidney cancer	0.000292	0.0012	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—TCEB1—kidney cancer	0.000292	0.0012	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—TCEB2—kidney cancer	0.000292	0.0012	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000291	0.0012	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000291	0.0012	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000289	0.00119	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000287	0.00118	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000285	0.00117	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP1A1—kidney cancer	0.00028	0.00115	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.00028	0.00115	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000279	0.00115	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000277	0.00114	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HNF1B—kidney cancer	0.000277	0.00114	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000277	0.00114	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000277	0.00114	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000277	0.00114	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000277	0.00114	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—RPL14—kidney cancer	0.000276	0.00114	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000275	0.00113	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000273	0.00112	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000273	0.00112	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—kidney cancer	0.00027	0.00111	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EIF5B—kidney cancer	0.00027	0.00111	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000268	0.0011	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000266	0.00109	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000265	0.00109	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000263	0.00108	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000257	0.00106	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—RPL14—kidney cancer	0.000253	0.00104	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—RPL14—kidney cancer	0.000248	0.00102	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ACY1—kidney cancer	0.000247	0.00101	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000242	0.000994	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—RPL14—kidney cancer	0.000238	0.000978	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—RPL14—kidney cancer	0.000238	0.000978	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000232	0.000953	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000229	0.000941	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—HSPB1—kidney cancer	0.000225	0.000927	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—EIF4EBP1—kidney cancer	0.000225	0.000927	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000222	0.000915	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000219	0.000902	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000218	0.000895	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000213	0.000877	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00021	0.000865	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PDHB—kidney cancer	0.00021	0.000863	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PSMD7—kidney cancer	0.000209	0.000862	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—POMC—kidney cancer	0.000209	0.00086	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000209	0.000858	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—EIF4EBP1—kidney cancer	0.000206	0.000848	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—HSPB1—kidney cancer	0.000206	0.000848	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000206	0.000845	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—HSPB1—kidney cancer	0.000202	0.000831	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—EIF4EBP1—kidney cancer	0.000202	0.000831	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000202	0.000831	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CTNNA1—kidney cancer	0.000199	0.000817	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CCBL1—kidney cancer	0.000197	0.000811	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000197	0.000811	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—HSPB1—kidney cancer	0.000194	0.000797	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—EIF4EBP1—kidney cancer	0.000194	0.000797	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HSPB1—kidney cancer	0.000194	0.000797	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—EIF4EBP1—kidney cancer	0.000194	0.000797	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PSMD7—kidney cancer	0.000192	0.000788	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PAX6—kidney cancer	0.00019	0.000782	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000189	0.000777	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—JUNB—kidney cancer	0.000188	0.000773	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PSMD7—kidney cancer	0.000188	0.000773	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CTNNB1—kidney cancer	0.000187	0.000768	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000183	0.000751	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000181	0.000745	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PSMD7—kidney cancer	0.00018	0.000741	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PSMD7—kidney cancer	0.00018	0.000741	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000178	0.000734	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000175	0.00072	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—JUNB—kidney cancer	0.000175	0.00072	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EEF2—kidney cancer	0.000174	0.000715	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—JUNB—kidney cancer	0.000172	0.000707	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GLIPR1—kidney cancer	0.000171	0.000703	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PPAT—kidney cancer	0.000171	0.000703	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000169	0.000694	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—JUNB—kidney cancer	0.000169	0.000694	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000167	0.000687	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—TET2—kidney cancer	0.000167	0.000685	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PAK1—kidney cancer	0.000165	0.000678	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—JUNB—kidney cancer	0.000162	0.000665	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—JUNB—kidney cancer	0.000162	0.000665	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—APRT—kidney cancer	0.000159	0.000654	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—FH—kidney cancer	0.000159	0.000654	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000159	0.000652	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000157	0.000645	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000155	0.000639	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000153	0.000631	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—CDKN2B—kidney cancer	0.000153	0.00063	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—TCEB2—kidney cancer	0.000152	0.000627	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—TCEB1—kidney cancer	0.000152	0.000627	CbGpPWpGaD
Isotretinoin—Nausea—Erlotinib—kidney cancer	0.00015	0.000205	CcSEcCtD
Isotretinoin—Alopecia—Capecitabine—kidney cancer	0.00015	0.000205	CcSEcCtD
Isotretinoin—Dry mouth—Paclitaxel—kidney cancer	0.00015	0.000205	CcSEcCtD
Isotretinoin—Mood swings—Doxorubicin—kidney cancer	0.00015	0.000204	CcSEcCtD
Isotretinoin—Diarrhoea—Sunitinib—kidney cancer	0.00015	0.000204	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GPC3—kidney cancer	0.000149	0.000615	CbGpPWpGaD
Isotretinoin—Mental disorder—Capecitabine—kidney cancer	0.000149	0.000203	CcSEcCtD
Isotretinoin—Asthenia—Dactinomycin—kidney cancer	0.000149	0.000203	CcSEcCtD
Isotretinoin—Confusional state—Paclitaxel—kidney cancer	0.000149	0.000202	CcSEcCtD
Isotretinoin—Blood creatinine increased—Doxorubicin—kidney cancer	0.000149	0.000202	CcSEcCtD
Isotretinoin—Malnutrition—Capecitabine—kidney cancer	0.000148	0.000202	CcSEcCtD
Isotretinoin—Erythema—Capecitabine—kidney cancer	0.000148	0.000202	CcSEcCtD
Isotretinoin—Dehydration—Doxorubicin—kidney cancer	0.000147	0.000201	CcSEcCtD
Isotretinoin—Oedema—Paclitaxel—kidney cancer	0.000147	0.000201	CcSEcCtD
Isotretinoin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000147	0.000201	CcSEcCtD
Isotretinoin—Body temperature increased—Vincristine—kidney cancer	0.000147	0.0002	CcSEcCtD
Isotretinoin—Abdominal pain—Vincristine—kidney cancer	0.000147	0.0002	CcSEcCtD
Isotretinoin—Infection—Paclitaxel—kidney cancer	0.000146	0.000199	CcSEcCtD
Isotretinoin—Flatulence—Capecitabine—kidney cancer	0.000146	0.000199	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000146	0.0006	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CA2—kidney cancer	0.000145	0.000598	CbGpPWpGaD
Isotretinoin—Dry skin—Doxorubicin—kidney cancer	0.000145	0.000198	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000145	0.000597	CbGpPWpGaD
Isotretinoin—Dizziness—Sunitinib—kidney cancer	0.000145	0.000197	CcSEcCtD
Isotretinoin—Feeling abnormal—Gemcitabine—kidney cancer	0.000145	0.000197	CcSEcCtD
Isotretinoin—Shock—Paclitaxel—kidney cancer	0.000145	0.000197	CcSEcCtD
Isotretinoin—Vomiting—Sorafenib—kidney cancer	0.000145	0.000197	CcSEcCtD
Isotretinoin—Nervous system disorder—Paclitaxel—kidney cancer	0.000144	0.000197	CcSEcCtD
Isotretinoin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000144	0.000196	CcSEcCtD
Isotretinoin—Tachycardia—Paclitaxel—kidney cancer	0.000144	0.000196	CcSEcCtD
Isotretinoin—Rash—Sorafenib—kidney cancer	0.000144	0.000196	CcSEcCtD
Isotretinoin—Dermatitis—Sorafenib—kidney cancer	0.000144	0.000195	CcSEcCtD
Isotretinoin—Back pain—Capecitabine—kidney cancer	0.000143	0.000195	CcSEcCtD
Isotretinoin—Skin disorder—Paclitaxel—kidney cancer	0.000143	0.000195	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000143	0.000194	CcSEcCtD
Isotretinoin—Headache—Sorafenib—kidney cancer	0.000143	0.000194	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000142	0.000586	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000142	0.000194	CcSEcCtD
Isotretinoin—Diarrhoea—Dactinomycin—kidney cancer	0.000142	0.000193	CcSEcCtD
Isotretinoin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000142	0.000193	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ALAD—kidney cancer	0.000142	0.000583	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000141	0.00058	CbGpPWpGaD
Isotretinoin—Anorexia—Paclitaxel—kidney cancer	0.00014	0.000191	CcSEcCtD
Isotretinoin—Gastritis—Doxorubicin—kidney cancer	0.00014	0.000191	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—CDKN2B—kidney cancer	0.00014	0.000576	CbGpPWpGaD
Isotretinoin—Vision blurred—Capecitabine—kidney cancer	0.00014	0.00019	CcSEcCtD
Isotretinoin—Vomiting—Sunitinib—kidney cancer	0.000139	0.00019	CcSEcCtD
Isotretinoin—Body temperature increased—Gemcitabine—kidney cancer	0.000139	0.000189	CcSEcCtD
Isotretinoin—Tremor—Capecitabine—kidney cancer	0.000139	0.000189	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000139	0.00057	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ST3GAL2—kidney cancer	0.000138	0.000569	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000138	0.000569	CbGpPWpGaD
Isotretinoin—Rash—Sunitinib—kidney cancer	0.000138	0.000188	CcSEcCtD
Isotretinoin—Dermatitis—Sunitinib—kidney cancer	0.000138	0.000188	CcSEcCtD
Isotretinoin—Abdominal distension—Doxorubicin—kidney cancer	0.000138	0.000188	CcSEcCtD
Isotretinoin—Hypotension—Paclitaxel—kidney cancer	0.000138	0.000187	CcSEcCtD
Isotretinoin—Ill-defined disorder—Capecitabine—kidney cancer	0.000137	0.000187	CcSEcCtD
Isotretinoin—Headache—Sunitinib—kidney cancer	0.000137	0.000187	CcSEcCtD
Isotretinoin—RARB—Gene Expression—CDKN2B—kidney cancer	0.000137	0.000565	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000137	0.000564	CbGpPWpGaD
Isotretinoin—Dysphagia—Doxorubicin—kidney cancer	0.000137	0.000187	CcSEcCtD
Isotretinoin—Asthma—Doxorubicin—kidney cancer	0.000137	0.000187	CcSEcCtD
Isotretinoin—Anaemia—Capecitabine—kidney cancer	0.000137	0.000186	CcSEcCtD
Isotretinoin—Hypersensitivity—Vincristine—kidney cancer	0.000137	0.000186	CcSEcCtD
Isotretinoin—Nausea—Sorafenib—kidney cancer	0.000135	0.000184	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ALDH1A1—kidney cancer	0.000135	0.000556	CbGpPWpGaD
Isotretinoin—Pancreatitis—Doxorubicin—kidney cancer	0.000134	0.000183	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000134	0.000183	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000134	0.00055	CbGpPWpGaD
Isotretinoin—Malaise—Capecitabine—kidney cancer	0.000134	0.000182	CcSEcCtD
Isotretinoin—Insomnia—Paclitaxel—kidney cancer	0.000133	0.000181	CcSEcCtD
Isotretinoin—Asthenia—Vincristine—kidney cancer	0.000133	0.000181	CcSEcCtD
Isotretinoin—Syncope—Capecitabine—kidney cancer	0.000133	0.000181	CcSEcCtD
Isotretinoin—Paraesthesia—Paclitaxel—kidney cancer	0.000132	0.00018	CcSEcCtD
Isotretinoin—Vomiting—Dactinomycin—kidney cancer	0.000132	0.00018	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—CDKN2B—kidney cancer	0.000132	0.000541	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—CDKN2B—kidney cancer	0.000132	0.000541	CbGpPWpGaD
Isotretinoin—Dyspnoea—Paclitaxel—kidney cancer	0.000131	0.000179	CcSEcCtD
Isotretinoin—Somnolence—Paclitaxel—kidney cancer	0.000131	0.000178	CcSEcCtD
Isotretinoin—Palpitations—Capecitabine—kidney cancer	0.000131	0.000178	CcSEcCtD
Isotretinoin—Rash—Dactinomycin—kidney cancer	0.000131	0.000178	CcSEcCtD
Isotretinoin—Nausea—Sunitinib—kidney cancer	0.00013	0.000177	CcSEcCtD
Isotretinoin—Loss of consciousness—Capecitabine—kidney cancer	0.00013	0.000177	CcSEcCtD
Isotretinoin—Dyspepsia—Paclitaxel—kidney cancer	0.00013	0.000177	CcSEcCtD
Isotretinoin—RXRA—Metabolism—SLC5A3—kidney cancer	0.00013	0.000533	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PGK1—kidney cancer	0.00013	0.000533	CbGpPWpGaD
Isotretinoin—Cough—Capecitabine—kidney cancer	0.000129	0.000176	CcSEcCtD
Isotretinoin—Dysuria—Doxorubicin—kidney cancer	0.000128	0.000174	CcSEcCtD
Isotretinoin—Neutropenia—Doxorubicin—kidney cancer	0.000128	0.000174	CcSEcCtD
Isotretinoin—Decreased appetite—Paclitaxel—kidney cancer	0.000128	0.000174	CcSEcCtD
Isotretinoin—Hypertension—Capecitabine—kidney cancer	0.000128	0.000174	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000127	0.000173	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000127	0.000173	CcSEcCtD
Isotretinoin—RXRA—Metabolism—LDHB—kidney cancer	0.000127	0.000523	CbGpPWpGaD
Isotretinoin—Fatigue—Paclitaxel—kidney cancer	0.000127	0.000173	CcSEcCtD
Isotretinoin—Diarrhoea—Vincristine—kidney cancer	0.000127	0.000173	CcSEcCtD
Isotretinoin—Pollakiuria—Doxorubicin—kidney cancer	0.000127	0.000172	CcSEcCtD
Isotretinoin—Asthenia—Gemcitabine—kidney cancer	0.000126	0.000172	CcSEcCtD
Isotretinoin—Arthralgia—Capecitabine—kidney cancer	0.000126	0.000172	CcSEcCtD
Isotretinoin—Chest pain—Capecitabine—kidney cancer	0.000126	0.000172	CcSEcCtD
Isotretinoin—Myalgia—Capecitabine—kidney cancer	0.000126	0.000172	CcSEcCtD
Isotretinoin—Constipation—Paclitaxel—kidney cancer	0.000126	0.000171	CcSEcCtD
Isotretinoin—Pain—Paclitaxel—kidney cancer	0.000126	0.000171	CcSEcCtD
Isotretinoin—Anxiety—Capecitabine—kidney cancer	0.000126	0.000171	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000125	0.00017	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000125	0.00017	CcSEcCtD
Isotretinoin—Weight increased—Doxorubicin—kidney cancer	0.000125	0.00017	CcSEcCtD
Isotretinoin—Discomfort—Capecitabine—kidney cancer	0.000125	0.00017	CcSEcCtD
Isotretinoin—Pruritus—Gemcitabine—kidney cancer	0.000124	0.000169	CcSEcCtD
Isotretinoin—Weight decreased—Doxorubicin—kidney cancer	0.000124	0.000169	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—RPL14—kidney cancer	0.000124	0.000509	CbGpPWpGaD
Isotretinoin—Dry mouth—Capecitabine—kidney cancer	0.000123	0.000168	CcSEcCtD
Isotretinoin—Nausea—Dactinomycin—kidney cancer	0.000123	0.000168	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—kidney cancer	0.000123	0.000507	CbGpPWpGaD
Isotretinoin—Pneumonia—Doxorubicin—kidney cancer	0.000123	0.000167	CcSEcCtD
Isotretinoin—Dizziness—Vincristine—kidney cancer	0.000123	0.000167	CcSEcCtD
Isotretinoin—Drowsiness—Doxorubicin—kidney cancer	0.000122	0.000166	CcSEcCtD
Isotretinoin—Infestation NOS—Doxorubicin—kidney cancer	0.000122	0.000166	CcSEcCtD
Isotretinoin—Infestation—Doxorubicin—kidney cancer	0.000122	0.000166	CcSEcCtD
Isotretinoin—Confusional state—Capecitabine—kidney cancer	0.000122	0.000166	CcSEcCtD
Isotretinoin—Feeling abnormal—Paclitaxel—kidney cancer	0.000121	0.000165	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000121	0.000165	CcSEcCtD
Isotretinoin—Oedema—Capecitabine—kidney cancer	0.000121	0.000165	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000121	0.000497	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00012	0.000164	CcSEcCtD
Isotretinoin—Diarrhoea—Gemcitabine—kidney cancer	0.00012	0.000164	CcSEcCtD
Isotretinoin—Renal failure—Doxorubicin—kidney cancer	0.00012	0.000163	CcSEcCtD
Isotretinoin—Infection—Capecitabine—kidney cancer	0.00012	0.000163	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.00012	0.000163	CcSEcCtD
Isotretinoin—Stomatitis—Doxorubicin—kidney cancer	0.000119	0.000162	CcSEcCtD
Isotretinoin—Shock—Capecitabine—kidney cancer	0.000119	0.000162	CcSEcCtD
Isotretinoin—Conjunctivitis—Doxorubicin—kidney cancer	0.000119	0.000162	CcSEcCtD
Isotretinoin—Urinary tract infection—Doxorubicin—kidney cancer	0.000119	0.000162	CcSEcCtD
Isotretinoin—Nervous system disorder—Capecitabine—kidney cancer	0.000119	0.000161	CcSEcCtD
Isotretinoin—Thrombocytopenia—Capecitabine—kidney cancer	0.000118	0.000161	CcSEcCtD
Isotretinoin—Tachycardia—Capecitabine—kidney cancer	0.000118	0.000161	CcSEcCtD
Isotretinoin—Vomiting—Vincristine—kidney cancer	0.000118	0.000161	CcSEcCtD
Isotretinoin—Skin disorder—Capecitabine—kidney cancer	0.000117	0.00016	CcSEcCtD
Isotretinoin—Sweating—Doxorubicin—kidney cancer	0.000117	0.000159	CcSEcCtD
Isotretinoin—Urticaria—Paclitaxel—kidney cancer	0.000117	0.000159	CcSEcCtD
Isotretinoin—Rash—Vincristine—kidney cancer	0.000117	0.000159	CcSEcCtD
Isotretinoin—Hyperhidrosis—Capecitabine—kidney cancer	0.000117	0.000159	CcSEcCtD
Isotretinoin—Dermatitis—Vincristine—kidney cancer	0.000117	0.000159	CcSEcCtD
Isotretinoin—Haematuria—Doxorubicin—kidney cancer	0.000116	0.000159	CcSEcCtD
Isotretinoin—Body temperature increased—Paclitaxel—kidney cancer	0.000116	0.000159	CcSEcCtD
Isotretinoin—Abdominal pain—Paclitaxel—kidney cancer	0.000116	0.000159	CcSEcCtD
Isotretinoin—Headache—Vincristine—kidney cancer	0.000116	0.000158	CcSEcCtD
Isotretinoin—Epistaxis—Doxorubicin—kidney cancer	0.000115	0.000157	CcSEcCtD
Isotretinoin—Anorexia—Capecitabine—kidney cancer	0.000115	0.000157	CcSEcCtD
Isotretinoin—Sinusitis—Doxorubicin—kidney cancer	0.000115	0.000156	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000114	0.00047	CbGpPWpGaD
Isotretinoin—Agranulocytosis—Doxorubicin—kidney cancer	0.000114	0.000155	CcSEcCtD
Isotretinoin—Hypotension—Capecitabine—kidney cancer	0.000113	0.000154	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—kidney cancer	0.000113	0.000463	CbGpPWpGaD
Isotretinoin—Vomiting—Gemcitabine—kidney cancer	0.000112	0.000152	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000111	0.000458	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000111	0.000457	CbGpPWpGaD
Isotretinoin—Rash—Gemcitabine—kidney cancer	0.000111	0.000151	CcSEcCtD
Isotretinoin—Dermatitis—Gemcitabine—kidney cancer	0.000111	0.000151	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—kidney cancer	0.000111	0.000455	CbGpPWpGaD
Isotretinoin—Haemoglobin—Doxorubicin—kidney cancer	0.00011	0.00015	CcSEcCtD
Isotretinoin—Headache—Gemcitabine—kidney cancer	0.00011	0.00015	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CA9—kidney cancer	0.00011	0.000453	CbGpPWpGaD
Isotretinoin—Nausea—Vincristine—kidney cancer	0.00011	0.00015	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00011	0.00015	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—kidney cancer	0.00011	0.000149	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—kidney cancer	0.00011	0.000149	CcSEcCtD
Isotretinoin—Insomnia—Capecitabine—kidney cancer	0.000109	0.000149	CcSEcCtD
Isotretinoin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000109	0.000149	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—kidney cancer	0.000109	0.000148	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000109	0.000447	CbGpPWpGaD
Isotretinoin—Paraesthesia—Capecitabine—kidney cancer	0.000109	0.000148	CcSEcCtD
Isotretinoin—Hypersensitivity—Paclitaxel—kidney cancer	0.000109	0.000148	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000108	0.000147	CcSEcCtD
Isotretinoin—Oedema peripheral—Doxorubicin—kidney cancer	0.000108	0.000147	CcSEcCtD
Isotretinoin—Dyspnoea—Capecitabine—kidney cancer	0.000108	0.000147	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000108	0.000443	CbGpPWpGaD
Isotretinoin—Urethral disorder—Doxorubicin—kidney cancer	0.000107	0.000146	CcSEcCtD
Isotretinoin—Dyspepsia—Capecitabine—kidney cancer	0.000106	0.000145	CcSEcCtD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—kidney cancer	0.000106	0.000436	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—kidney cancer	0.000106	0.000436	CbGpPWpGaD
Isotretinoin—Visual impairment—Doxorubicin—kidney cancer	0.000106	0.000144	CcSEcCtD
Isotretinoin—Asthenia—Paclitaxel—kidney cancer	0.000106	0.000144	CcSEcCtD
Isotretinoin—Decreased appetite—Capecitabine—kidney cancer	0.000105	0.000143	CcSEcCtD
Isotretinoin—Nausea—Gemcitabine—kidney cancer	0.000104	0.000142	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000104	0.000142	CcSEcCtD
Isotretinoin—Fatigue—Capecitabine—kidney cancer	0.000104	0.000142	CcSEcCtD
Isotretinoin—Pruritus—Paclitaxel—kidney cancer	0.000104	0.000142	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—kidney cancer	0.000104	0.000141	CcSEcCtD
Isotretinoin—Constipation—Capecitabine—kidney cancer	0.000103	0.000141	CcSEcCtD
Isotretinoin—Pain—Capecitabine—kidney cancer	0.000103	0.000141	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000103	0.000422	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KDR—kidney cancer	0.000103	0.000422	CbGpPWpGaD
Isotretinoin—Eye disorder—Doxorubicin—kidney cancer	0.000102	0.00014	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—kidney cancer	0.000102	0.000139	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—kidney cancer	0.000102	0.000139	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—HSPB1—kidney cancer	0.000101	0.000415	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EIF4EBP1—kidney cancer	0.000101	0.000415	CbGpPWpGaD
Isotretinoin—Diarrhoea—Paclitaxel—kidney cancer	0.000101	0.000137	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MET—kidney cancer	0.0001	0.000413	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Capecitabine—kidney cancer	9.96e-05	0.000136	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—kidney cancer	9.95e-05	0.000135	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Capecitabine—kidney cancer	9.88e-05	0.000135	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—kidney cancer	9.84e-05	0.000134	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—kidney cancer	9.8e-05	0.000133	CcSEcCtD
Isotretinoin—Dizziness—Paclitaxel—kidney cancer	9.74e-05	0.000133	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—kidney cancer	9.69e-05	0.000132	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—kidney cancer	9.61e-05	0.000131	CcSEcCtD
Isotretinoin—Urticaria—Capecitabine—kidney cancer	9.6e-05	0.000131	CcSEcCtD
Isotretinoin—Abdominal pain—Capecitabine—kidney cancer	9.55e-05	0.00013	CcSEcCtD
Isotretinoin—Body temperature increased—Capecitabine—kidney cancer	9.55e-05	0.00013	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—kidney cancer	9.55e-05	0.00013	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—kidney cancer	9.55e-05	0.00013	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.44e-05	0.000388	CbGpPWpGaD
Isotretinoin—Flatulence—Doxorubicin—kidney cancer	9.41e-05	0.000128	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—PSMD7—kidney cancer	9.39e-05	0.000386	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CRABP1—kidney cancer	9.37e-05	0.000385	CbGpPWpGaD
Isotretinoin—Tension—Doxorubicin—kidney cancer	9.37e-05	0.000128	CcSEcCtD
Isotretinoin—Vomiting—Paclitaxel—kidney cancer	9.36e-05	0.000127	CcSEcCtD
Isotretinoin—Rash—Paclitaxel—kidney cancer	9.29e-05	0.000126	CcSEcCtD
Isotretinoin—Dermatitis—Paclitaxel—kidney cancer	9.28e-05	0.000126	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—kidney cancer	9.27e-05	0.000126	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—kidney cancer	9.23e-05	0.000126	CcSEcCtD
Isotretinoin—Headache—Paclitaxel—kidney cancer	9.23e-05	0.000126	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.13e-05	0.000375	CbGpPWpGaD
Isotretinoin—Vision blurred—Doxorubicin—kidney cancer	9e-05	0.000122	CcSEcCtD
Isotretinoin—Hypersensitivity—Capecitabine—kidney cancer	8.9e-05	0.000121	CcSEcCtD
Isotretinoin—Ill-defined disorder—Doxorubicin—kidney cancer	8.86e-05	0.000121	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—kidney cancer	8.82e-05	0.00012	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—kidney cancer	8.77e-05	0.000119	CcSEcCtD
Isotretinoin—Nausea—Paclitaxel—kidney cancer	8.75e-05	0.000119	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ITPR2—kidney cancer	8.71e-05	0.000358	CbGpPWpGaD
Isotretinoin—Asthenia—Capecitabine—kidney cancer	8.67e-05	0.000118	CcSEcCtD
Isotretinoin—Malaise—Doxorubicin—kidney cancer	8.61e-05	0.000117	CcSEcCtD
Isotretinoin—Syncope—Doxorubicin—kidney cancer	8.56e-05	0.000117	CcSEcCtD
Isotretinoin—Pruritus—Capecitabine—kidney cancer	8.55e-05	0.000116	CcSEcCtD
Isotretinoin—Palpitations—Doxorubicin—kidney cancer	8.44e-05	0.000115	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—JUNB—kidney cancer	8.43e-05	0.000347	CbGpPWpGaD
Isotretinoin—Loss of consciousness—Doxorubicin—kidney cancer	8.39e-05	0.000114	CcSEcCtD
Isotretinoin—Cough—Doxorubicin—kidney cancer	8.33e-05	0.000113	CcSEcCtD
Isotretinoin—Convulsion—Doxorubicin—kidney cancer	8.27e-05	0.000113	CcSEcCtD
Isotretinoin—Diarrhoea—Capecitabine—kidney cancer	8.27e-05	0.000113	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—kidney cancer	8.24e-05	0.000112	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—kidney cancer	8.13e-05	0.000111	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—kidney cancer	8.13e-05	0.000111	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—kidney cancer	8.13e-05	0.000111	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—kidney cancer	8.1e-05	0.00011	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	8.07e-05	0.00011	CcSEcCtD
Isotretinoin—Discomfort—Doxorubicin—kidney cancer	8.03e-05	0.000109	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.03e-05	0.00033	CbGpPWpGaD
Isotretinoin—Dizziness—Capecitabine—kidney cancer	7.99e-05	0.000109	CcSEcCtD
Isotretinoin—Dry mouth—Doxorubicin—kidney cancer	7.95e-05	0.000108	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GSTT1—kidney cancer	7.94e-05	0.000327	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ACHE—kidney cancer	7.94e-05	0.000327	CbGpPWpGaD
Isotretinoin—Confusional state—Doxorubicin—kidney cancer	7.86e-05	0.000107	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—kidney cancer	7.79e-05	0.000106	CcSEcCtD
Isotretinoin—Oedema—Doxorubicin—kidney cancer	7.79e-05	0.000106	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—kidney cancer	7.74e-05	0.000105	CcSEcCtD
Isotretinoin—Vomiting—Capecitabine—kidney cancer	7.68e-05	0.000105	CcSEcCtD
Isotretinoin—Shock—Doxorubicin—kidney cancer	7.67e-05	0.000104	CcSEcCtD
Isotretinoin—Nervous system disorder—Doxorubicin—kidney cancer	7.64e-05	0.000104	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—kidney cancer	7.63e-05	0.000104	CcSEcCtD
Isotretinoin—Rash—Capecitabine—kidney cancer	7.62e-05	0.000104	CcSEcCtD
Isotretinoin—Dermatitis—Capecitabine—kidney cancer	7.61e-05	0.000104	CcSEcCtD
Isotretinoin—Tachycardia—Doxorubicin—kidney cancer	7.6e-05	0.000104	CcSEcCtD
Isotretinoin—Headache—Capecitabine—kidney cancer	7.57e-05	0.000103	CcSEcCtD
Isotretinoin—Skin disorder—Doxorubicin—kidney cancer	7.57e-05	0.000103	CcSEcCtD
Isotretinoin—Hyperhidrosis—Doxorubicin—kidney cancer	7.53e-05	0.000103	CcSEcCtD
Isotretinoin—RXRA—Metabolism—SCARB1—kidney cancer	7.52e-05	0.000309	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS1—kidney cancer	7.44e-05	0.000306	CbGpPWpGaD
Isotretinoin—Anorexia—Doxorubicin—kidney cancer	7.43e-05	0.000101	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—RAF1—kidney cancer	7.41e-05	0.000305	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—RELA—kidney cancer	7.38e-05	0.000304	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ERBB2—kidney cancer	7.33e-05	0.000302	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PSMD7—kidney cancer	7.3e-05	0.0003	CbGpPWpGaD
Isotretinoin—Hypotension—Doxorubicin—kidney cancer	7.28e-05	9.91e-05	CcSEcCtD
Isotretinoin—Nausea—Capecitabine—kidney cancer	7.18e-05	9.77e-05	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.1e-05	9.66e-05	CcSEcCtD
Isotretinoin—Insomnia—Doxorubicin—kidney cancer	7.05e-05	9.59e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Doxorubicin—kidney cancer	7e-05	9.52e-05	CcSEcCtD
Isotretinoin—Dyspnoea—Doxorubicin—kidney cancer	6.95e-05	9.46e-05	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—kidney cancer	6.93e-05	9.43e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—BCHE—kidney cancer	6.92e-05	0.000285	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CDKN2B—kidney cancer	6.86e-05	0.000282	CbGpPWpGaD
Isotretinoin—Dyspepsia—Doxorubicin—kidney cancer	6.86e-05	9.34e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—SLC5A5—kidney cancer	6.83e-05	0.000281	CbGpPWpGaD
Isotretinoin—Decreased appetite—Doxorubicin—kidney cancer	6.77e-05	9.22e-05	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.73e-05	9.16e-05	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—kidney cancer	6.72e-05	9.14e-05	CcSEcCtD
Isotretinoin—Pain—Doxorubicin—kidney cancer	6.66e-05	9.07e-05	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—kidney cancer	6.66e-05	9.07e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—SLC2A1—kidney cancer	6.6e-05	0.000272	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Doxorubicin—kidney cancer	6.42e-05	8.74e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—CTNNB1—kidney cancer	6.42e-05	0.000264	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.4e-05	0.000263	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Doxorubicin—kidney cancer	6.37e-05	8.67e-05	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—RAF1—kidney cancer	6.29e-05	0.000259	CbGpPWpGaD
Isotretinoin—Urticaria—Doxorubicin—kidney cancer	6.19e-05	8.43e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—kidney cancer	6.16e-05	8.38e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—kidney cancer	6.16e-05	8.38e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—MAPK3—kidney cancer	6.1e-05	0.000251	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—kidney cancer	5.93e-05	0.000244	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Doxorubicin—kidney cancer	5.74e-05	7.81e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—VEGFA—kidney cancer	5.65e-05	0.000232	CbGpPWpGaD
Isotretinoin—Asthenia—Doxorubicin—kidney cancer	5.59e-05	7.61e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.59e-05	0.00023	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MAPK3—kidney cancer	5.58e-05	0.000229	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—kidney cancer	5.52e-05	0.000227	CbGpPWpGaD
Isotretinoin—Pruritus—Doxorubicin—kidney cancer	5.51e-05	7.5e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GSTP1—kidney cancer	5.51e-05	0.000226	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MAPK3—kidney cancer	5.47e-05	0.000225	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—kidney cancer	5.43e-05	0.000223	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAPK3—kidney cancer	5.34e-05	0.00022	CbGpPWpGaD
Isotretinoin—Diarrhoea—Doxorubicin—kidney cancer	5.33e-05	7.26e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—MYC—kidney cancer	5.32e-05	0.000219	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MAPK3—kidney cancer	5.24e-05	0.000216	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MAPK3—kidney cancer	5.24e-05	0.000216	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCB1—kidney cancer	5.21e-05	0.000214	CbGpPWpGaD
Isotretinoin—Dizziness—Doxorubicin—kidney cancer	5.15e-05	7.01e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—MYC—kidney cancer	5.1e-05	0.00021	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—kidney cancer	5.1e-05	0.00021	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAPK1—kidney cancer	5.08e-05	0.000209	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTM1—kidney cancer	5.06e-05	0.000208	CbGpPWpGaD
Isotretinoin—Vomiting—Doxorubicin—kidney cancer	4.95e-05	6.74e-05	CcSEcCtD
Isotretinoin—Rash—Doxorubicin—kidney cancer	4.91e-05	6.69e-05	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—kidney cancer	4.91e-05	6.68e-05	CcSEcCtD
Isotretinoin—Headache—Doxorubicin—kidney cancer	4.88e-05	6.64e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—KRAS—kidney cancer	4.8e-05	0.000198	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1A1—kidney cancer	4.8e-05	0.000197	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—kidney cancer	4.63e-05	6.3e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.94e-05	0.000162	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—POMC—kidney cancer	3.58e-05	0.000147	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—kidney cancer	2.85e-05	0.000117	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MAPK3—kidney cancer	2.73e-05	0.000112	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—kidney cancer	2.66e-05	0.000109	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—kidney cancer	2.49e-05	0.000102	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—kidney cancer	1.75e-05	7.22e-05	CbGpPWpGaD
